Summary
Researchers presented a clinical case in which the use of Yashtimadhu (Glycyrrhiza glabra) in a Basti Ksheerapaka demonstrated therapeutic potential in managing oligohydramnios, a condition characterized by low amniotic fluid levels. The treatment was administered to a pregnant woman with oligohydramnios, resulting in significant improvement in amniotic fluid levels and the overall health of the mother and fetus. Basti, an Ayurvedic therapy involving the administration of medicinal liquids into the rectum, was prepared with Yashtimadhu, which is known for its anti-inflammatory and hydrating properties. This case highlights the importance of integrative approaches in maternal and child health and suggests that Ayurveda may offer valuable alternatives in challenging obstetric situations. However, the study is limited to a single case, which requires further investigation to validate these findings.
Key points
- Yashtimadhu (Glycyrrhiza glabra) has anti-inflammatory properties that may benefit gestational health.
- Basti Ksheerapaka is a therapy that uses medicinal liquids, enhancing the absorption and efficacy of the ingredients.
- Oligohydramnios was successfully treated, resulting in an increase in amniotic fluid levels after treatment.
✦ For you
If you are pregnant and notice signs of decreased amniotic fluid, consider monitoring your hydration and the quality of your diet. Adequate intake of fluids and nutritious foods may help maintain a healthy environment for the baby. If you have concerns, seek a qualified healthcare professional.
For practitionersExpand
Consider including Yashtimadhu (Glycyrrhiza glabra) in treatment protocols for pregnant women with oligohydramnios, especially in cases where conventional approaches are insufficient. Assess the patient's overall condition and adjust the Basti formulation as needed, always respecting contraindications and the particularities of pregnancy.